|
| |
Anna Lee & Charles Gomersall
Updated June 2006
Pharmacology
Mechanism of action
Poisoning
Presentation
- clinical effects due to nervous system stimulation
- CNS effects: euphoria, agitation, confusion, seizures, hyperthermia
- peripheral vasomotor stimulation by norepinephrine results in tachycardia and
hypertension
Complications
CNS complications
- acute psychosis
- TIA, cerebral haemorrhage, cerebral oedema, cerebral vasculitis and
ischaemia
CVS complications
- arrhythmias, myocardial ischaemia and infarction, myocarditis
- aortic rupture secondary to severe hypertension
- sudden death. Due to combination of coronary vasoconstriction causing
myocardial ischaemia, VT and increased BP. Can occur irrespective of amount
ingested, prior use or route of administration and without underlying heart
disease. May be
delayed up to 24hr
Pulmonary complications
- status asthmaticus
- upper airway obstruction
- barotrauma
- due to forceful Valsalva manoeuvres that are performed during smoking
- pulmonary oedema
- cardiogenic
- negative pressure (during smoking)
- capillary leak due to cocaine induced microangiopathy
Other complications
- hyperthermia leading to DIC
- rhabdomyolysis with acute renal failure
- bowel ischaemia and infarction
Differential diagnosis
- other conditions causing hypoxia, fits or both
- may mimic neuroleptic malignant syndrome or acute withdrawal from sedatives or
ethanol
- in pregnant patients: pre-eclampsia/eclampsia
Management
Management of body packer
-
Plain AXR as screening test
-
For symptomatic patient, immediate surgical removal of
the package is indicated. Other treatment as mentioned above
© Anna Lee & Charles Gomersall, June 2006
|